Download Updated 2019 Prostate Cancer Patient Guide

Prostate Cancer Foundation’s goal is always to deliver the most cutting-edge treatments and information to families dealing with prostate cancer. As such, they have committed to updating the patient guide to reflect the very latest research and discoveries for patients.¬†

This is the second round of updates for 2019. Changes include:

  • Updated information on active surveillance
  • Revised guidance on when to start discussions of screening with physician aligned with NCCN recommendations (age 40 for African Americans, age 45 for average-risk men)
  • Additional details on indications for, and side effects of, second-generation anti-androgen drugs, including late-breaking approval of darolutamide for non-metastatic castration-resistant prostate cancer
  • Expanded section on treatment of metastatic hormone-sensitive prostate cancer
  • Information on commercially available genetic testing
  • Guidance on talking to your insurance company

Download an updated digital copy today and then be sure to provide feedback.